Topic

Prostate cancer Steady

1,425 applications whose title mentions it. Its share of new filings over the last two years is -7% below the four years before.

Allowance rate

52%

−23 pts vs the USPTO 1,218 decided

Months to first action

18.8 mo

+0.2 vs the USPTO

Applications

1,425.0

in the record

Allowed

637.0

581 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K421 apps

C12Q396 apps

G01N269 apps

C07K95 apps

G16H47 apps

C12N45 apps

Art units

1642194 apps

1634158 apps

164383 apps

OPAP75 apps

162967 apps

168260 apps

Examiners

Who examines it, and how it fares with each

Sean E Aeder91 apps

53%

Docket Central73 apps

n/a

Katherine D Salmon36 apps

53%

Mark Halvorson29 apps

39%

Sheela Jitendra Huff27 apps

85%

Juliet Caroline Switzer23 apps

76%

Jeanine Anne Goldberg19 apps

29%

Amanda Marie Haney19 apps

35%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT43 apps

58%

The Johns Hopkins University38 apps

50%

The Regents of the University of California31 apps

46%

Immatics Biotechnologies GmbH22 apps

86%

Janssen Pharmaceutica NV22 apps

50%

University of Pittsburgh - Of the Commonwealth System of Higher Education18 apps

88%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

Casimir Jones, S.C.56 apps

69%

BakerHostetler51 apps

54%

FOLEY & LARDNER LLP43 apps

47%

McBee Moore & Vanik, IP, LLC25 apps

83%

Knobbe, Martens, Olson & Bear, LLP22 apps

46%

WOLF GREENFIELD & SACKS, P.C.22 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19881537	DUAL PARP/HDAC INHIBITOR FOR TREATING BREAST CANCER, OVARIAN CANCER, AND PROSTATE C…	2026-10-01	Pending	0	0	n/a
19617978	APPLICATION OF PRIMERS AND PROBES FOR DETECTING PROSTATE CANCER SPECIFIC METHYLATIO…	2026-08-24	Pending	0	0	n/a
19613680	METHODS AND MATERIALS FOR TREATING PROSTATE CANCER	2026-08-07	Pending	0	0	n/a
15338939	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15616188	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15597504	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15864547	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15379563	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15835473	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15658563	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in